p.R358L | TCGA-44-7661 | LUAD | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.8428 |
p.R358L | TCGA-CN-6010 | HNSC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.8428 |
p.E369K | TCGA-A5-A2K5 | UCEC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0556 |
p.D353N | TCGA-B5-A3FC | UCEC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D353N | TCGA-FI-A2D5 | UCEC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D353N | DO41871 | UCEC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D353N | DO41331 | UCEC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D353N | SIDM00145 | T-Lymphoblastic Leukemia | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D353N | MOLT-4 | haematopoietic_and_lymphoid_tissue | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.V361M | TCGA-EC-A1QX | UCEC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.2778 |
p.D342N | TCGA-EO-A22U | UCEC | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0556 |
p.D342N | DO43755 | UCEC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0556 |
p.G351S | TCGA-IB-7651 | PAAD | TCGA | PPFTPDFE | DEG_SCF_FBW7_2 | 0.3056 |
p.G351S | DO46657 | PAAD | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.3056 |
p.D343G | DO233258 | GACA | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0833 |
p.T364I | DO233709 | GACA | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.1944 |
p.R348L | DO14766 | HNSC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.2222 |
p.R348L | DO23602 | LUAD | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.2222 |
p.T362S | DO26922 | LUSC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.25 |
p.V351M | DO42592 | UCEC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.3056 |
p.E359K | DO41379 | UCEC | ICGC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.7022 |
p.D359N | SIDM01007 | T-Lymphoblastic Leukemia | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.D359N | KARPAS-45 | haematopoietic_and_lymphoid_tissue | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.6932 |
p.P347R | SIDM00202 | Ewing's Sarcoma | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.1944 |
p.P347R | SIDM00101 | Mesothelioma | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.1944 |
p.S360N | SIDM00333 | Endometrial Carcinoma | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.3056 |
p.S360N | MFE-319 | endometrium | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.3056 |
p.R344Q | SIDM00958 | Chronic Myelogenous Leukemia | GDSC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.1111 |
p.R344Q | CML-T1 | haematopoietic_and_lymphoid_tissue | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.1111 |
p.S350N | ACH-000988 | Endometrial/Uterine Cancer | CCLE | PPFTPDFE | DEG_SCF_FBW7_2 | 0.2778 |
p.S350N | MFE-319 | endometrium | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.2778 |
p.D343N | ACH-001127 | Leukemia | CCLE | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0833 |
p.D343N | MOLT-4 | haematopoietic_and_lymphoid_tissue | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.0833 |
p.D349N | ACH-002256 | Leukemia | CCLE | PPFTPDFE | DEG_SCF_FBW7_2 | 0.25 |
p.D349N | KARPAS-45 | haematopoietic_and_lymphoid_tissue | COSMIC | PPFTPDFE | DEG_SCF_FBW7_2 | 0.25 |